NCT00413296 - Levetiracetam in Post-Traumatic Stress Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

September 30, 2007

Study Completion Date

March 31, 2008

Conditions

Post-Traumatic Stress Disorder

Interventions

DRUG

levetiracetam

Tablets, dosage 500 mg each ( 1-6 tablets/day)for20 wks

DRUG

Placebo

Placebo, Tablets, no active ingredient in the tablets, (1-6tablets/day)for 12 wks in the 2nd phase of the study.

DRUG

Levetriracetam

Tablets, 500 mg each (1-6 tablets/day) for 8 wks during the open label phase and for 12 wks during the 2nd phase of the study.

Trial Locations (1)

Duke University Medical Center, Durham